Evaluation of Combination Therapy With Miglustat and Enzyme Replacement Therapy on Gaucher Disease Type IIIB
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 27 Mar 2018
At a glance
- Drugs Miglustat (Primary) ; Enzyme replacements
- Indications Gaucher's disease type III
- Focus Therapeutic Use
- 20 Mar 2018 Planned End Date changed from 1 Jul 2018 to 1 Dec 2018.
- 20 Mar 2018 Status changed from recruiting to active, no longer recruiting.
- 18 Aug 2015 New trial record